海特生物：2025年前三季度净利润约-1.58亿元

Group 1 - The core viewpoint of the article highlights the financial performance of Hite Bio, indicating a decline in revenue and a significant net loss for the third quarter of 2025 [1] - Hite Bio reported revenue of approximately 422 million yuan for the first three quarters of 2025, representing a year-on-year decrease of 6.45% [1] - The net profit attributable to shareholders of the listed company was a loss of approximately 158 million yuan, with basic earnings per share reflecting a loss of 1.21 yuan [1] Group 2 - As of the report, Hite Bio has a market capitalization of 4.5 billion yuan [2]